<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01674582</url>
  </required_header>
  <id_info>
    <org_study_id>Version1.0</org_study_id>
    <nct_id>NCT01674582</nct_id>
  </id_info>
  <brief_title>Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters</brief_title>
  <official_title>Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lund University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purposes with this trial is to investigate the potential of MRI with diffusion and
      blood volume, flow in brain to diagnose and to measure treatment effects in patients with
      intracranial tumors, especially gliomas and metastases in a prospective trial, to evaluate
      the possibilities to individually adjusted treatment in this category of patients depending
      on treatment outcomes measured by MRI, to perform clinical follow up in connection with MRI
      to evaluate a correlation and to perform testing of cognitive ability before, during, and
      after treatment and to investigate if given treatment causes any decrease in the patients
      habitual state.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early prediction of treatment response based on MRI parameters.</measure>
    <time_frame>Three weeks compared to baseline.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuropsychological function.</measure>
    <time_frame>Month 3, 12, and 18 compared to baseline</time_frame>
    <description>Neuropsychological testing to evaluate the correlation between MRI results and neuropsychological status in participating patients. This applies for 80 patients of 150 of the patient population.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Intracranial Tumor</condition>
  <arm_group>
    <arm_group_label>MRI, Neuropsychological testing</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI, neuropsychological evaluation, blood sampling</intervention_name>
    <description>MRI at timepoints given above, neuropsychological testing after surgery, but before radiotherapy or chemotherapy.
Neuropsychological testing month 3 during treatment. Neuropsychological testing after 1 year. Neuropsychological testing after 2 years.</description>
    <arm_group_label>MRI, Neuropsychological testing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Suspected primary brain tumor, verified glioblastoma or non surgically treated
             metastases from solid tumor

          -  Increasing MRI changes in patients with previous verified glioblastoma

          -  Be able to speak Swedish without difficulties (because of the neuropsychological
             investigations)

          -  Written informed concent

        Exclusion Criteria:

          -  Unability to perform MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pia Maly Sundgren, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sk√•ne University Hospital-Lund</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pia Maly Sundgren, MD, PhD</last_name>
    <phone>+46 46 17 10 00</phone>
    <email>pia.sundgren@med.lu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara Kinhult, MD, PhD</last_name>
    <phone>+46 46 17 75 20</phone>
    <email>sara.kinhult@med.lu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lund University Hospital</name>
      <address>
        <city>Lund</city>
        <zip>221 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle van Westen, MD, PhD</last_name>
      <phone>+46 46</phone>
      <email>danielle.vanwesten@skane.se</email>
    </contact>
    <contact_backup>
      <last_name>Sara Kinhult, MD, PhD</last_name>
      <phone>+46 46 17 75 20</phone>
      <email>sara.kinhult@med.lu.se</email>
    </contact_backup>
    <investigator>
      <last_name>Danielle van Westen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2012</study_first_submitted>
  <study_first_submitted_qc>August 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2012</study_first_posted>
  <last_update_submitted>March 9, 2018</last_update_submitted>
  <last_update_submitted_qc>March 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glioma</keyword>
  <keyword>Brain tumors</keyword>
  <keyword>Brain metastases</keyword>
  <keyword>MRI</keyword>
  <keyword>Cognitive measurement</keyword>
  <keyword>Neuropsychological evaluation</keyword>
  <keyword>DW-MRI</keyword>
  <keyword>P-MRI</keyword>
  <keyword>MRS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

